Aardvark Therapeutics AARD
NASDAQ AARD
$3.97 -0.44 (-9.98%)
As of: Oct 22, 2026 · 3:28 PM EDT

Aardvark Therapeutics (AARD) Other non-cash items (2024 - 2026)

Updated

Analysis

Aardvark Therapeutics (AARD) Other non-cash items (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,169.70 Bn 1,138.29 Bn 19.71 Bn
2 Johnson & Johnson 647.50 Bn 567.36 Bn 17.30 Bn
3 AbbVie 504.26 Bn 477.37 Bn 12.70 Bn
4 Merck 368.38 Bn 322.75 Bn 12.21 Bn
5 Novartis Ag 303.14 Bn 267.13 Bn 11.24 Bn
6 Astrazeneca 268.24 Bn 241.93 Bn 12.86 Bn
7 Amgen 242.50 Bn 197.90 Bn 7.24 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn
9 Pfizer 173.14 Bn 119.78 Bn 10.94 Bn
10 Aardvark Therapeutics 86.73 Mn 12.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 89,000.00
Mar 31, 2026 86,000.00
Dec 31, 2025 84,000.00
Mar 31, 2025 107,000.00
Dec 31, 2024 106,000.00
Jun 30, 2024 14,000.00
Mar 31, 2024 128,000.00
API Access

Aardvark Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=AARD&period=max&api_key=YOUR_API_KEY